XML 132 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Identifiable Intangible Assets and Goodwill (Details Textual) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Dec. 31, 2012
Jun. 30, 2012
Dec. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Home Health [Member]
Dec. 31, 2012
Home Health [Member]
Dec. 31, 2013
Hospice [Member]
Mar. 31, 2013
Hospice [Member]
Dec. 31, 2013
Hospice [Member]
Dec. 31, 2012
Hospice [Member]
Dec. 31, 2013
Community Care [Member]
Dec. 31, 2011
Home Health and Hospice [Member]
Dec. 31, 2012
Impairment of Intangible Assets [Member]
Oct. 18, 2013
Harden Healthcare Holdings Inc. [Member]
Oct. 18, 2013
Harden Healthcare Holdings Inc. [Member]
Home Health [Member]
Oct. 18, 2013
Harden Healthcare Holdings Inc. [Member]
Hospice [Member]
Oct. 18, 2013
Harden Healthcare Holdings Inc. [Member]
Community Care [Member]
Goodwill [Line Items]                                          
Discount rate 9.90%                 10.60%   9.50%   9.50%              
Goodwill, intangibles and other long-lived asset impairment         $ (643,300,000) $ (610,436,000) [1] $ (19,132,000) [1] $ (643,305,000) [1]   $ (408,400,000) $ (386,100,000)     $ (193,700,000)   $ 602,100,000 [1]          
Goodwill 390,081,000   656,364,000   641,669,000 390,081,000 656,364,000 641,669,000 123,500,000 9,000,000 150,000,000   150,000,000 647,300,000 116,600,000     331,482,000 111,700,000 103,100,000 116,600,000
Indefinite-lived intangible assets, period increase (decrease)           (1,400,000) (1,100,000)                            
Goodwill, Impairment Loss   220,800,000       600,636,000     0     220,800,000 600,636,000                
Goodwill impairment test, net book value of reporting unit                       555,000,000                  
Number of branches divested                 46       13                
Amortization expense           4,800,000 10,000,000 13,000,000                          
Estimated amortization expense for 2014 5,700,000         5,700,000                              
Estimated amortization expense for 2015 4,100,000         4,100,000                              
Estimated amortization expense for 2016 3,100,000         3,100,000                              
Estimated amortization expense for 2017 2,400,000         2,400,000                              
Estimated amortization expense for 2018 1,600,000         1,600,000                              
Impairment of intangible assets, finite-lived   224,300,000         19,100,000   6,000,000       13,100,000                
Gain (loss) on sale of business     2,600,000 5,400,000   0 8,014,000 1,061,000                 700,000        
Operating expenses           $ 701,716,000 $ 655,766,000 $ 730,407,000                 $ 400,000        
Business Acquisition,Goodwill, Expected tax Deductible Percent                                   20.00%      
[1] The Company performed its annual impairment test as of December 31, 2013 for its Home Health, Hospice and Community Care segments. Based on this assessment, the Company recorded non-cash impairment charges relating to the goodwill and intangibles of its Hospice segment of approximately $379.8 million and $6.3 million, respectively, for the year 2013.At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million. As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million. Hospice and corporate assets were reduced by $220.8 million and $3.5 million, respectively, as a result of these impairments.For the year ended December 31, 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of December 31, 2012 as a result of the impairment.For the year ended December 31, 2011, the Company recorded non-cash impairment charges associated with goodwill, intangibles and other long-lived assets of $643.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a significant decline in the price of the Company's common stock during the fiscal year, (iv) a write-down of software and (v) a change in the estimated fair value of real estate. Home Health, Hospice and corporate assets were reduced by $408.4 million, $193.7 million and $41.2 million, respectively, as of December 31, 2011, as a result of the impairment.